Product Program year 2025 Source: CMS Open Payments

Nit-Occlud Pda

Device Congenital Heart Defect Devices

PDI 04042301159939

Open in the dashboard

General payments

$179,173

283 payments

Research payments

$0

0 payments

Through program year 2025, $179,173 in general payments and $0 in research payments were reported against Nit-Occlud Pda (Congenital Heart Defect Devices).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $99,720 139
2024 General $59,080 94
2023 General $5,955 30
2022 General $13,193 18
2021 General $1,225 2

Breakdown

Who paid General payments · program years 2021–2025
  1. B. Braun Interventional Systems Inc. $178,480 280 payments
  2. Aesculap, Inc. $692 3 payments
Top recipients General payments · program year 2025
  1. Thomas Forbes Pediatric Cardiology · Detroit, MI $42,795 43% · 40 payments
  2. Juan Samayoa Escobar Pediatric Cardiology · Minneapolis, MN $9,929 10% · 13 payments
  3. Gareth Morgan Interventional Cardiology · Aurora, CO $8,367 8% · 11 payments
  4. Jenny Zablah Alabi Interventional Cardiology · Aurora, CO $6,422 6% · 16 payments
  5. Ada Stefanescu Interventional Cardiology · Boston, MA $6,345 6% · 6 payments

The top 5 of 41 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Pediatric Cardiology Pediatrics $66,962 71% · 19 practitioners
  2. Interventional Cardiology Internal Medicine $21,289 23% · 7 practitioners
  3. Pediatrics $5,075 5% · 1 practitioner
  4. Cardiovascular Disease Internal Medicine $139 <1% · 2 practitioners
  5. Anesthesiology $70 <1% · 3 practitioners

The top 5 of 10 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Michigan $42,795 43% · 1 recipient
  2. Minnesota $15,004 15% · 2 recipients
  3. Colorado $14,789 15% · 2 recipients
  4. Massachusetts $6,467 6% · 2 recipients
  5. North Carolina $6,054 6% · 1 recipient

The top 5 of 16 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

283 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record